Hu, J., Zhang, J., Li, L., Wang, S., Yang, H., Fan, X., . . . Kong, B. (2021). PU.1 inhibition attenuates atrial fibrosis and atrial fibrillation vulnerability induced by angiotensin‐II by reducing TGF‐β1/Smads pathway activation. J Cell Mol Med.
Styl ChicagoHu, Juan, et al. "PU.1 Inhibition Attenuates Atrial Fibrosis and Atrial Fibrillation Vulnerability Induced By Angiotensin‐II By Reducing TGF‐β1/Smads Pathway Activation." J Cell Mol Med 2021.
Citace podle MLAHu, Juan, et al. "PU.1 Inhibition Attenuates Atrial Fibrosis and Atrial Fibrillation Vulnerability Induced By Angiotensin‐II By Reducing TGF‐β1/Smads Pathway Activation." J Cell Mol Med 2021.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..